nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Mesalazine—ulcerative colitis	0.55	1	CrCtD
L-DOPA—Mesalazine—Olsalazine—ulcerative colitis	0.0841	0.24	CrCrCtD
L-DOPA—Aminosalicylic Acid—Mesalazine—ulcerative colitis	0.0718	0.205	CrCrCtD
L-DOPA—Carbidopa—Mesalazine—ulcerative colitis	0.054	0.154	CrCrCtD
L-DOPA—Methyldopa—Mesalazine—ulcerative colitis	0.0467	0.133	CrCrCtD
L-DOPA—Droxidopa—Mesalazine—ulcerative colitis	0.0467	0.133	CrCrCtD
L-DOPA—Dopamine—Mesalazine—ulcerative colitis	0.0467	0.133	CrCrCtD
L-DOPA—SLC7A5—Balsalazide—Olsalazine—ulcerative colitis	0.000837	0.407	CbGdCrCtD
L-DOPA—PSIP1—lymphoid tissue—ulcerative colitis	0.000638	0.104	CbGeAlD
L-DOPA—PSIP1—digestive system—ulcerative colitis	0.000631	0.103	CbGeAlD
L-DOPA—SLC7A5—Balsalazide—Sulfasalazine—ulcerative colitis	0.000481	0.234	CbGdCrCtD
L-DOPA—PSIP1—liver—ulcerative colitis	0.00047	0.0767	CbGeAlD
L-DOPA—SLC7A5—epithelium—ulcerative colitis	0.000423	0.0691	CbGeAlD
L-DOPA—SLC7A5—smooth muscle tissue—ulcerative colitis	0.000408	0.0666	CbGeAlD
L-DOPA—SLC15A1—epithelium—ulcerative colitis	0.000351	0.0574	CbGeAlD
L-DOPA—DRD5—lymphoid tissue—ulcerative colitis	0.00035	0.0572	CbGeAlD
L-DOPA—SLC7A5—lymphoid tissue—ulcerative colitis	0.000326	0.0532	CbGeAlD
L-DOPA—SLC16A10—epithelium—ulcerative colitis	0.000324	0.0529	CbGeAlD
L-DOPA—SLC7A5—digestive system—ulcerative colitis	0.000322	0.0526	CbGeAlD
L-DOPA—SLC7A8—liver—ulcerative colitis	0.00031	0.0506	CbGeAlD
L-DOPA—Aminosalicylic Acid—MPO—ulcerative colitis	0.000275	0.109	CrCbGaD
L-DOPA—DDC—liver—ulcerative colitis	0.000268	0.0437	CbGeAlD
L-DOPA—SLC15A1—digestive system—ulcerative colitis	0.000267	0.0436	CbGeAlD
L-DOPA—SLC16A10—lymphoid tissue—ulcerative colitis	0.00025	0.0408	CbGeAlD
L-DOPA—Isoetarine—ADRB2—ulcerative colitis	0.000249	0.0987	CrCbGaD
L-DOPA—SLC7A5—liver—ulcerative colitis	0.00024	0.0392	CbGeAlD
L-DOPA—Mesalazine—MPO—ulcerative colitis	0.000216	0.0855	CrCbGaD
L-DOPA—SLC15A1—liver—ulcerative colitis	0.000199	0.0325	CbGeAlD
L-DOPA—Mesalazine—PPARG—ulcerative colitis	0.000192	0.0759	CrCbGaD
L-DOPA—SLC16A10—liver—ulcerative colitis	0.000184	0.03	CbGeAlD
L-DOPA—Aminosalicylic Acid—PTGS1—ulcerative colitis	0.000181	0.0714	CrCbGaD
L-DOPA—Norepinephrine—SLC22A5—ulcerative colitis	0.000165	0.0653	CrCbGaD
L-DOPA—Dopamine—SLC22A5—ulcerative colitis	0.000154	0.0607	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Budesonide—ulcerative colitis	0.000151	0.0736	CbGdCrCtD
L-DOPA—Epinephrine—SLC22A5—ulcerative colitis	0.00015	0.0593	CrCbGaD
L-DOPA—Mesalazine—PTGS1—ulcerative colitis	0.000142	0.056	CrCbGaD
L-DOPA—Droxidopa—ADRB2—ulcerative colitis	0.000114	0.0451	CrCbGaD
L-DOPA—Isoprenaline—ADRB2—ulcerative colitis	0.000104	0.041	CrCbGaD
L-DOPA—Aminosalicylic Acid—PTGS2—ulcerative colitis	0.000103	0.0408	CrCbGaD
L-DOPA—Epinephrine—TNF—ulcerative colitis	9.82e-05	0.0388	CrCbGaD
L-DOPA—Norepinephrine—ADRB2—ulcerative colitis	9.59e-05	0.0379	CrCbGaD
L-DOPA—CYP2D6—digestive system—ulcerative colitis	9.38e-05	0.0153	CbGeAlD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—ulcerative colitis	8.95e-05	0.0436	CbGdCrCtD
L-DOPA—Epinephrine—ADRB2—ulcerative colitis	8.7e-05	0.0344	CrCbGaD
L-DOPA—Mesalazine—PTGS2—ulcerative colitis	8.1e-05	0.032	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—ulcerative colitis	7.74e-05	0.0377	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—ulcerative colitis	7.31e-05	0.0356	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—ulcerative colitis	7.19e-05	0.035	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—ulcerative colitis	7.19e-05	0.035	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—ulcerative colitis	7.03e-05	0.0342	CbGdCrCtD
L-DOPA—CYP2D6—liver—ulcerative colitis	6.99e-05	0.0114	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—ulcerative colitis	6.67e-05	0.0325	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—ulcerative colitis	6.51e-05	0.0317	CbGdCrCtD
L-DOPA—Liothyronine—ALB—ulcerative colitis	6.21e-05	0.0246	CrCbGaD
L-DOPA—Liothyronine—ABCB1—ulcerative colitis	5.93e-05	0.0234	CrCbGaD
L-DOPA—Loss of consciousness—Prednisolone—ulcerative colitis	5.91e-05	0.000988	CcSEcCtD
L-DOPA—Vomiting—Budesonide—ulcerative colitis	5.89e-05	0.000985	CcSEcCtD
L-DOPA—Syncope—Hydrocortisone—ulcerative colitis	5.89e-05	0.000985	CcSEcCtD
L-DOPA—Rash—Budesonide—ulcerative colitis	5.84e-05	0.000977	CcSEcCtD
L-DOPA—Dermatitis—Budesonide—ulcerative colitis	5.83e-05	0.000976	CcSEcCtD
L-DOPA—Convulsion—Prednisolone—ulcerative colitis	5.82e-05	0.000974	CcSEcCtD
L-DOPA—Headache—Budesonide—ulcerative colitis	5.8e-05	0.000971	CcSEcCtD
L-DOPA—Hypertension—Prednisolone—ulcerative colitis	5.8e-05	0.000971	CcSEcCtD
L-DOPA—Loss of consciousness—Hydrocortisone—ulcerative colitis	5.77e-05	0.000965	CcSEcCtD
L-DOPA—Arrhythmia—Dexamethasone—ulcerative colitis	5.75e-05	0.000963	CcSEcCtD
L-DOPA—Arrhythmia—Betamethasone—ulcerative colitis	5.75e-05	0.000963	CcSEcCtD
L-DOPA—Ill-defined disorder—Triamcinolone—ulcerative colitis	5.73e-05	0.000959	CcSEcCtD
L-DOPA—Ill-defined disorder—Methylprednisolone—ulcerative colitis	5.72e-05	0.000957	CcSEcCtD
L-DOPA—Alopecia—Dexamethasone—ulcerative colitis	5.69e-05	0.000952	CcSEcCtD
L-DOPA—Alopecia—Betamethasone—ulcerative colitis	5.69e-05	0.000952	CcSEcCtD
L-DOPA—Convulsion—Hydrocortisone—ulcerative colitis	5.69e-05	0.000951	CcSEcCtD
L-DOPA—Hypertension—Hydrocortisone—ulcerative colitis	5.67e-05	0.000948	CcSEcCtD
L-DOPA—Diarrhoea—Azathioprine—ulcerative colitis	5.66e-05	0.000947	CcSEcCtD
L-DOPA—Discomfort—Prednisolone—ulcerative colitis	5.65e-05	0.000946	CcSEcCtD
L-DOPA—Angioedema—Triamcinolone—ulcerative colitis	5.65e-05	0.000945	CcSEcCtD
L-DOPA—Haemoglobin—Prednisone—ulcerative colitis	5.64e-05	0.000943	CcSEcCtD
L-DOPA—Angioedema—Methylprednisolone—ulcerative colitis	5.63e-05	0.000943	CcSEcCtD
L-DOPA—Haemorrhage—Prednisone—ulcerative colitis	5.61e-05	0.000939	CcSEcCtD
L-DOPA—Hallucination—Prednisone—ulcerative colitis	5.58e-05	0.000934	CcSEcCtD
L-DOPA—Malaise—Triamcinolone—ulcerative colitis	5.57e-05	0.000932	CcSEcCtD
L-DOPA—Anxiety—Hydrocortisone—ulcerative colitis	5.57e-05	0.000932	CcSEcCtD
L-DOPA—Malaise—Methylprednisolone—ulcerative colitis	5.56e-05	0.00093	CcSEcCtD
L-DOPA—Hypersensitivity—Mesalazine—ulcerative colitis	5.55e-05	0.000928	CcSEcCtD
L-DOPA—Syncope—Triamcinolone—ulcerative colitis	5.54e-05	0.000927	CcSEcCtD
L-DOPA—Syncope—Methylprednisolone—ulcerative colitis	5.53e-05	0.000925	CcSEcCtD
L-DOPA—Discomfort—Hydrocortisone—ulcerative colitis	5.52e-05	0.000924	CcSEcCtD
L-DOPA—Nausea—Budesonide—ulcerative colitis	5.5e-05	0.00092	CcSEcCtD
L-DOPA—Oedema—Prednisolone—ulcerative colitis	5.48e-05	0.000918	CcSEcCtD
L-DOPA—Dizziness—Azathioprine—ulcerative colitis	5.47e-05	0.000915	CcSEcCtD
L-DOPA—Loss of consciousness—Triamcinolone—ulcerative colitis	5.43e-05	0.000909	CcSEcCtD
L-DOPA—Loss of consciousness—Methylprednisolone—ulcerative colitis	5.42e-05	0.000907	CcSEcCtD
L-DOPA—Asthenia—Mesalazine—ulcerative colitis	5.4e-05	0.000904	CcSEcCtD
L-DOPA—Shock—Prednisolone—ulcerative colitis	5.4e-05	0.000903	CcSEcCtD
L-DOPA—Cough—Triamcinolone—ulcerative colitis	5.39e-05	0.000902	CcSEcCtD
L-DOPA—Oedema—Hydrocortisone—ulcerative colitis	5.36e-05	0.000896	CcSEcCtD
L-DOPA—Convulsion—Triamcinolone—ulcerative colitis	5.35e-05	0.000896	CcSEcCtD
L-DOPA—Convulsion—Methylprednisolone—ulcerative colitis	5.34e-05	0.000894	CcSEcCtD
L-DOPA—Hypertension—Triamcinolone—ulcerative colitis	5.34e-05	0.000893	CcSEcCtD
L-DOPA—Pruritus—Mesalazine—ulcerative colitis	5.33e-05	0.000892	CcSEcCtD
L-DOPA—Hypertension—Methylprednisolone—ulcerative colitis	5.32e-05	0.000891	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisolone—ulcerative colitis	5.3e-05	0.000887	CcSEcCtD
L-DOPA—Shock—Hydrocortisone—ulcerative colitis	5.27e-05	0.000882	CcSEcCtD
L-DOPA—Vomiting—Azathioprine—ulcerative colitis	5.26e-05	0.00088	CcSEcCtD
L-DOPA—Anxiety—Methylprednisolone—ulcerative colitis	5.23e-05	0.000875	CcSEcCtD
L-DOPA—Rash—Azathioprine—ulcerative colitis	5.21e-05	0.000872	CcSEcCtD
L-DOPA—Dermatitis—Azathioprine—ulcerative colitis	5.21e-05	0.000872	CcSEcCtD
L-DOPA—Flushing—Prednisone—ulcerative colitis	5.21e-05	0.000871	CcSEcCtD
L-DOPA—Ill-defined disorder—Betamethasone—ulcerative colitis	5.2e-05	0.00087	CcSEcCtD
L-DOPA—Ill-defined disorder—Dexamethasone—ulcerative colitis	5.2e-05	0.00087	CcSEcCtD
L-DOPA—Discomfort—Triamcinolone—ulcerative colitis	5.2e-05	0.00087	CcSEcCtD
L-DOPA—Discomfort—Methylprednisolone—ulcerative colitis	5.19e-05	0.000868	CcSEcCtD
L-DOPA—Headache—Azathioprine—ulcerative colitis	5.18e-05	0.000867	CcSEcCtD
L-DOPA—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.18e-05	0.000866	CcSEcCtD
L-DOPA—Diarrhoea—Mesalazine—ulcerative colitis	5.15e-05	0.000862	CcSEcCtD
L-DOPA—Dry mouth—Triamcinolone—ulcerative colitis	5.15e-05	0.000861	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—ulcerative colitis	5.12e-05	0.000857	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—ulcerative colitis	5.12e-05	0.000857	CcSEcCtD
L-DOPA—Anorexia—Hydrocortisone—ulcerative colitis	5.11e-05	0.000854	CcSEcCtD
L-DOPA—Confusional state—Methylprednisolone—ulcerative colitis	5.07e-05	0.000849	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—ulcerative colitis	5.06e-05	0.000846	CcSEcCtD
L-DOPA—Malaise—Betamethasone—ulcerative colitis	5.06e-05	0.000846	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—ulcerative colitis	5.04e-05	0.000844	CcSEcCtD
L-DOPA—Syncope—Betamethasone—ulcerative colitis	5.03e-05	0.000841	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—ulcerative colitis	5.03e-05	0.000841	CcSEcCtD
L-DOPA—Arrhythmia—Prednisone—ulcerative colitis	5.01e-05	0.000838	CcSEcCtD
L-DOPA—Hypotension—Hydrocortisone—ulcerative colitis	5.01e-05	0.000837	CcSEcCtD
L-DOPA—Dizziness—Mesalazine—ulcerative colitis	4.98e-05	0.000833	CcSEcCtD
L-DOPA—Shock—Triamcinolone—ulcerative colitis	4.96e-05	0.00083	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—ulcerative colitis	4.96e-05	0.00083	CcSEcCtD
L-DOPA—Alopecia—Prednisone—ulcerative colitis	4.96e-05	0.000829	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—ulcerative colitis	4.95e-05	0.000828	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—ulcerative colitis	4.93e-05	0.000825	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—ulcerative colitis	4.93e-05	0.000825	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—ulcerative colitis	4.93e-05	0.000824	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—ulcerative colitis	4.91e-05	0.000822	CcSEcCtD
L-DOPA—Nausea—Azathioprine—ulcerative colitis	4.91e-05	0.000822	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.88e-05	0.000816	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.87e-05	0.000814	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—ulcerative colitis	4.86e-05	0.000813	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—ulcerative colitis	4.86e-05	0.000813	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—ulcerative colitis	4.84e-05	0.000811	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—ulcerative colitis	4.84e-05	0.00081	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—ulcerative colitis	4.84e-05	0.00081	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—ulcerative colitis	4.81e-05	0.000805	CcSEcCtD
L-DOPA—Vomiting—Mesalazine—ulcerative colitis	4.79e-05	0.000801	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—ulcerative colitis	4.76e-05	0.000796	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—ulcerative colitis	4.76e-05	0.000796	CcSEcCtD
L-DOPA—Rash—Mesalazine—ulcerative colitis	4.75e-05	0.000795	CcSEcCtD
L-DOPA—Dermatitis—Mesalazine—ulcerative colitis	4.75e-05	0.000794	CcSEcCtD
L-DOPA—Headache—Mesalazine—ulcerative colitis	4.72e-05	0.000789	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—ulcerative colitis	4.72e-05	0.000789	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—ulcerative colitis	4.72e-05	0.000789	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—ulcerative colitis	4.72e-05	0.000789	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—ulcerative colitis	4.7e-05	0.000787	CcSEcCtD
L-DOPA—Pain—Prednisolone—ulcerative colitis	4.69e-05	0.000785	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—ulcerative colitis	4.66e-05	0.000779	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.62e-05	0.000774	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—ulcerative colitis	4.62e-05	0.000773	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—ulcerative colitis	4.6e-05	0.00077	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—ulcerative colitis	4.58e-05	0.000766	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—ulcerative colitis	4.58e-05	0.000766	CcSEcCtD
L-DOPA—Oedema—Betamethasone—ulcerative colitis	4.58e-05	0.000766	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—ulcerative colitis	4.56e-05	0.000763	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—ulcerative colitis	4.55e-05	0.000762	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—ulcerative colitis	4.53e-05	0.000758	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—ulcerative colitis	4.53e-05	0.000758	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—ulcerative colitis	4.52e-05	0.000756	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—ulcerative colitis	4.52e-05	0.000756	CcSEcCtD
L-DOPA—Anaemia—Prednisone—ulcerative colitis	4.51e-05	0.000755	CcSEcCtD
L-DOPA—Shock—Dexamethasone—ulcerative colitis	4.5e-05	0.000753	CcSEcCtD
L-DOPA—Shock—Betamethasone—ulcerative colitis	4.5e-05	0.000753	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—ulcerative colitis	4.5e-05	0.000752	CcSEcCtD
L-DOPA—Agitation—Prednisone—ulcerative colitis	4.49e-05	0.000751	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—ulcerative colitis	4.48e-05	0.00075	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.48e-05	0.00075	CcSEcCtD
L-DOPA—Nausea—Mesalazine—ulcerative colitis	4.47e-05	0.000749	CcSEcCtD
L-DOPA—Angioedema—Prednisone—ulcerative colitis	4.46e-05	0.000747	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—ulcerative colitis	4.44e-05	0.000743	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—ulcerative colitis	4.43e-05	0.000741	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.42e-05	0.00074	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—ulcerative colitis	4.42e-05	0.00074	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.41e-05	0.000738	CcSEcCtD
L-DOPA—Malaise—Prednisone—ulcerative colitis	4.4e-05	0.000737	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.38e-05	0.000733	CcSEcCtD
L-DOPA—Syncope—Prednisone—ulcerative colitis	4.38e-05	0.000733	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—ulcerative colitis	4.36e-05	0.00073	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—ulcerative colitis	4.36e-05	0.00073	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—ulcerative colitis	4.36e-05	0.000729	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—ulcerative colitis	4.35e-05	0.000728	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—ulcerative colitis	4.34e-05	0.000726	CcSEcCtD
L-DOPA—Pain—Triamcinolone—ulcerative colitis	4.31e-05	0.000722	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—ulcerative colitis	4.29e-05	0.000718	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—ulcerative colitis	4.28e-05	0.000715	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—ulcerative colitis	4.28e-05	0.000715	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—ulcerative colitis	4.26e-05	0.000712	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—ulcerative colitis	4.23e-05	0.000708	CcSEcCtD
L-DOPA—Convulsion—Prednisone—ulcerative colitis	4.23e-05	0.000708	CcSEcCtD
L-DOPA—Hypertension—Prednisone—ulcerative colitis	4.22e-05	0.000705	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—ulcerative colitis	4.16e-05	0.000695	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.15e-05	0.000694	CcSEcCtD
L-DOPA—Anxiety—Prednisone—ulcerative colitis	4.14e-05	0.000693	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—ulcerative colitis	4.14e-05	0.000692	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—ulcerative colitis	4.14e-05	0.000692	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.12e-05	0.000688	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—ulcerative colitis	4.11e-05	0.000688	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—ulcerative colitis	4.11e-05	0.000688	CcSEcCtD
L-DOPA—Discomfort—Prednisone—ulcerative colitis	4.11e-05	0.000687	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—ulcerative colitis	4.04e-05	0.000676	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—ulcerative colitis	4.03e-05	0.000674	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—ulcerative colitis	4.03e-05	0.000674	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—ulcerative colitis	4.01e-05	0.00067	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—ulcerative colitis	4e-05	0.000669	CcSEcCtD
L-DOPA—Oedema—Prednisone—ulcerative colitis	3.99e-05	0.000667	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—ulcerative colitis	3.98e-05	0.000666	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—ulcerative colitis	3.98e-05	0.000666	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—ulcerative colitis	3.98e-05	0.000666	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.95e-05	0.000661	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.95e-05	0.000661	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.95e-05	0.00066	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—ulcerative colitis	3.95e-05	0.00066	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—ulcerative colitis	3.95e-05	0.00066	CcSEcCtD
L-DOPA—Shock—Prednisone—ulcerative colitis	3.92e-05	0.000656	CcSEcCtD
L-DOPA—Pain—Betamethasone—ulcerative colitis	3.91e-05	0.000655	CcSEcCtD
L-DOPA—Pain—Dexamethasone—ulcerative colitis	3.91e-05	0.000655	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—ulcerative colitis	3.85e-05	0.000645	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—ulcerative colitis	3.84e-05	0.000643	CcSEcCtD
L-DOPA—Anorexia—Prednisone—ulcerative colitis	3.8e-05	0.000636	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—ulcerative colitis	3.79e-05	0.000634	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—ulcerative colitis	3.77e-05	0.000631	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—ulcerative colitis	3.77e-05	0.000631	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.74e-05	0.000626	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.74e-05	0.000626	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—ulcerative colitis	3.72e-05	0.000622	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.71e-05	0.00062	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—ulcerative colitis	3.67e-05	0.000613	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—ulcerative colitis	3.64e-05	0.000608	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—ulcerative colitis	3.64e-05	0.000608	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—ulcerative colitis	3.63e-05	0.000607	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—ulcerative colitis	3.62e-05	0.000605	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—ulcerative colitis	3.62e-05	0.000605	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—ulcerative colitis	3.62e-05	0.000605	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—ulcerative colitis	3.61e-05	0.000604	CcSEcCtD
L-DOPA—Insomnia—Prednisone—ulcerative colitis	3.6e-05	0.000603	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—ulcerative colitis	3.58e-05	0.000599	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—ulcerative colitis	3.57e-05	0.000597	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—ulcerative colitis	3.56e-05	0.000596	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—ulcerative colitis	3.54e-05	0.000593	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—ulcerative colitis	3.51e-05	0.000587	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—ulcerative colitis	3.46e-05	0.00058	CcSEcCtD
L-DOPA—Rash—Prednisolone—ulcerative colitis	3.46e-05	0.000579	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—ulcerative colitis	3.46e-05	0.000578	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—ulcerative colitis	3.44e-05	0.000576	CcSEcCtD
L-DOPA—Fatigue—Prednisone—ulcerative colitis	3.44e-05	0.000575	CcSEcCtD
L-DOPA—Headache—Prednisolone—ulcerative colitis	3.44e-05	0.000575	CcSEcCtD
L-DOPA—Constipation—Prednisone—ulcerative colitis	3.41e-05	0.00057	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—ulcerative colitis	3.41e-05	0.00057	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—ulcerative colitis	3.38e-05	0.000565	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—ulcerative colitis	3.37e-05	0.000565	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—ulcerative colitis	3.36e-05	0.000561	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—ulcerative colitis	3.34e-05	0.000558	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—ulcerative colitis	3.33e-05	0.000557	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—ulcerative colitis	3.28e-05	0.000549	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—ulcerative colitis	3.28e-05	0.000549	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—ulcerative colitis	3.28e-05	0.000549	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—ulcerative colitis	3.26e-05	0.000545	CcSEcCtD
L-DOPA—Nausea—Prednisolone—ulcerative colitis	3.26e-05	0.000545	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—ulcerative colitis	3.24e-05	0.000542	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—ulcerative colitis	3.24e-05	0.000542	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—ulcerative colitis	3.21e-05	0.000537	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—ulcerative colitis	3.2e-05	0.000535	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—ulcerative colitis	3.18e-05	0.000532	CcSEcCtD
L-DOPA—Rash—Triamcinolone—ulcerative colitis	3.18e-05	0.000532	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—ulcerative colitis	3.18e-05	0.000532	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—ulcerative colitis	3.17e-05	0.000531	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—ulcerative colitis	3.17e-05	0.00053	CcSEcCtD
L-DOPA—Urticaria—Prednisone—ulcerative colitis	3.17e-05	0.00053	CcSEcCtD
L-DOPA—Headache—Triamcinolone—ulcerative colitis	3.16e-05	0.000529	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—ulcerative colitis	3.15e-05	0.000527	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—ulcerative colitis	3.15e-05	0.000527	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—ulcerative colitis	3.13e-05	0.000524	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—ulcerative colitis	3.13e-05	0.000524	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—ulcerative colitis	3.03e-05	0.000506	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—ulcerative colitis	3.03e-05	0.000506	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—ulcerative colitis	3e-05	0.000501	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—ulcerative colitis	2.99e-05	0.0005	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—ulcerative colitis	2.94e-05	0.000491	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—ulcerative colitis	2.91e-05	0.000487	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—ulcerative colitis	2.91e-05	0.000487	CcSEcCtD
L-DOPA—Rash—Betamethasone—ulcerative colitis	2.89e-05	0.000483	CcSEcCtD
L-DOPA—Rash—Dexamethasone—ulcerative colitis	2.89e-05	0.000483	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—ulcerative colitis	2.88e-05	0.000482	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—ulcerative colitis	2.88e-05	0.000482	CcSEcCtD
L-DOPA—Headache—Betamethasone—ulcerative colitis	2.87e-05	0.00048	CcSEcCtD
L-DOPA—Headache—Dexamethasone—ulcerative colitis	2.87e-05	0.00048	CcSEcCtD
L-DOPA—Asthenia—Prednisone—ulcerative colitis	2.86e-05	0.000478	CcSEcCtD
L-DOPA—Pruritus—Prednisone—ulcerative colitis	2.82e-05	0.000472	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—ulcerative colitis	2.73e-05	0.000456	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—ulcerative colitis	2.72e-05	0.000455	CcSEcCtD
L-DOPA—Nausea—Betamethasone—ulcerative colitis	2.72e-05	0.000455	CcSEcCtD
L-DOPA—Dizziness—Prednisone—ulcerative colitis	2.64e-05	0.000441	CcSEcCtD
L-DOPA—Vomiting—Prednisone—ulcerative colitis	2.53e-05	0.000424	CcSEcCtD
L-DOPA—Rash—Prednisone—ulcerative colitis	2.51e-05	0.00042	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—ulcerative colitis	2.51e-05	0.00042	CcSEcCtD
L-DOPA—Headache—Prednisone—ulcerative colitis	2.5e-05	0.000418	CcSEcCtD
L-DOPA—Nausea—Prednisone—ulcerative colitis	2.37e-05	0.000396	CcSEcCtD
L-DOPA—DRD2—GPCR downstream signaling—CXCR1—ulcerative colitis	1.8e-05	0.000611	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GNA12—ulcerative colitis	1.79e-05	0.000606	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TGFB1—ulcerative colitis	1.78e-05	0.000606	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCR6—ulcerative colitis	1.77e-05	0.0006	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GNA12—ulcerative colitis	1.76e-05	0.000598	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—ADRB2—ulcerative colitis	1.76e-05	0.000598	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCR6—ulcerative colitis	1.75e-05	0.000595	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCR6—ulcerative colitis	1.73e-05	0.000587	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SEL1L—ulcerative colitis	1.72e-05	0.000585	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PTGER4—ulcerative colitis	1.71e-05	0.000582	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCR2—ulcerative colitis	1.69e-05	0.000575	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL20—ulcerative colitis	1.69e-05	0.000574	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—TP53—ulcerative colitis	1.68e-05	0.000572	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CALM3—ulcerative colitis	1.68e-05	0.000571	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCR2—ulcerative colitis	1.67e-05	0.000567	CbGpPWpGaD
L-DOPA—PSIP1—Disease—STAT3—ulcerative colitis	1.64e-05	0.000556	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCR1—ulcerative colitis	1.63e-05	0.000555	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.63e-05	0.000553	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.62e-05	0.000551	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—ADRB2—ulcerative colitis	1.6e-05	0.000543	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCR6—ulcerative colitis	1.59e-05	0.000541	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GNA12—ulcerative colitis	1.59e-05	0.000539	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCL20—ulcerative colitis	1.58e-05	0.000536	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCR6—ulcerative colitis	1.57e-05	0.000533	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—GHRL—ulcerative colitis	1.57e-05	0.000533	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—ADRB2—ulcerative colitis	1.56e-05	0.000531	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PTGER4—ulcerative colitis	1.56e-05	0.000529	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SEL1L—ulcerative colitis	1.55e-05	0.000527	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.54e-05	0.000524	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SEL1L—ulcerative colitis	1.53e-05	0.00052	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PTGER4—ulcerative colitis	1.52e-05	0.000517	CbGpPWpGaD
L-DOPA—PSIP1—Disease—TGFB1—ulcerative colitis	1.52e-05	0.000515	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCR2—ulcerative colitis	1.5e-05	0.000511	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CXCL8—ulcerative colitis	1.5e-05	0.000511	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—ADCY5—ulcerative colitis	1.49e-05	0.000507	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GNA12—ulcerative colitis	1.48e-05	0.000504	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TP53—ulcerative colitis	1.47e-05	0.000499	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.46e-05	0.000495	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL20—ulcerative colitis	1.43e-05	0.000487	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—GHRL—ulcerative colitis	1.42e-05	0.000484	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCR1—ulcerative colitis	1.42e-05	0.000482	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR6—ulcerative colitis	1.41e-05	0.000481	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—GHRL—ulcerative colitis	1.41e-05	0.00048	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCR2—ulcerative colitis	1.41e-05	0.000478	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PTGER4—ulcerative colitis	1.4e-05	0.000476	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—GHRL—ulcerative colitis	1.39e-05	0.000473	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PTGER4—ulcerative colitis	1.38e-05	0.00047	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CALM3—ulcerative colitis	1.38e-05	0.000469	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—ADCY5—ulcerative colitis	1.36e-05	0.000461	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GNA12—ulcerative colitis	1.35e-05	0.000458	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAML2—ulcerative colitis	1.34e-05	0.000456	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR6—ulcerative colitis	1.32e-05	0.000449	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.31e-05	0.000446	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ABCB1—ulcerative colitis	1.31e-05	0.000444	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—ADRB2—ulcerative colitis	1.3e-05	0.000441	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.29e-05	0.00044	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GHRL—ulcerative colitis	1.28e-05	0.000436	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCR2—ulcerative colitis	1.28e-05	0.000434	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCR1—ulcerative colitis	1.28e-05	0.000434	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—TP53—ulcerative colitis	1.27e-05	0.000433	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GHRL—ulcerative colitis	1.27e-05	0.00043	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCR1—ulcerative colitis	1.26e-05	0.000428	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.26e-05	0.000428	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL20—ulcerative colitis	1.25e-05	0.000423	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.25e-05	0.000423	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTGER4—ulcerative colitis	1.25e-05	0.000423	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CALM3—ulcerative colitis	1.24e-05	0.000422	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CALM3—ulcerative colitis	1.23e-05	0.000416	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ADCY5—ulcerative colitis	1.22e-05	0.000414	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR6—ulcerative colitis	1.2e-05	0.000408	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—ADRB2—ulcerative colitis	1.18e-05	0.000401	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GNA12—ulcerative colitis	1.17e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SEL1L—ulcerative colitis	1.17e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.17e-05	0.000397	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—ulcerative colitis	1.17e-05	0.000396	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PTGER4—ulcerative colitis	1.16e-05	0.000396	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—ADRB2—ulcerative colitis	1.15e-05	0.000392	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—TP53—ulcerative colitis	1.15e-05	0.00039	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—ulcerative colitis	1.14e-05	0.000388	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GHRL—ulcerative colitis	1.14e-05	0.000387	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—TP53—ulcerative colitis	1.13e-05	0.000385	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL20—ulcerative colitis	1.12e-05	0.000381	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCR2—ulcerative colitis	1.11e-05	0.000377	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CXCL8—ulcerative colitis	1.11e-05	0.000377	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL20—ulcerative colitis	1.11e-05	0.000376	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CALM3—ulcerative colitis	1.1e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—ADCY5—ulcerative colitis	1.1e-05	0.000374	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RIPK2—ulcerative colitis	1.09e-05	0.00037	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GHRL—ulcerative colitis	1.07e-05	0.000362	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ADRB2—ulcerative colitis	1.06e-05	0.000361	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PTGER4—ulcerative colitis	1.06e-05	0.000359	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GNA12—ulcerative colitis	1.05e-05	0.000358	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—ulcerative colitis	1.05e-05	0.000357	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ADRB2—ulcerative colitis	1.05e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR6—ulcerative colitis	1.04e-05	0.000355	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GNA12—ulcerative colitis	1.04e-05	0.000353	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—ulcerative colitis	1.04e-05	0.000352	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.03e-05	0.000349	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—ADCY5—ulcerative colitis	1e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCR2—ulcerative colitis	1e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CXCL8—ulcerative colitis	9.99e-06	0.000339	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	9.92e-06	0.000337	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	9.91e-06	0.000337	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAML2—ulcerative colitis	9.9e-06	0.000336	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCR2—ulcerative colitis	9.86e-06	0.000335	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CXCL8—ulcerative colitis	9.86e-06	0.000335	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—ADCY5—ulcerative colitis	9.79e-06	0.000333	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GHRL—ulcerative colitis	9.68e-06	0.000329	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCR1—ulcerative colitis	9.65e-06	0.000328	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADRB2—ulcerative colitis	9.44e-06	0.000321	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR6—ulcerative colitis	9.4e-06	0.000319	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CALM3—ulcerative colitis	9.38e-06	0.000319	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—JAK2—ulcerative colitis	9.31e-06	0.000316	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR6—ulcerative colitis	9.27e-06	0.000315	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTGER4—ulcerative colitis	9.19e-06	0.000312	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PPARG—ulcerative colitis	9.09e-06	0.000309	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ADCY5—ulcerative colitis	9.01e-06	0.000306	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAML2—ulcerative colitis	8.91e-06	0.000303	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ADCY5—ulcerative colitis	8.89e-06	0.000302	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DLD—ulcerative colitis	8.88e-06	0.000302	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADRB2—ulcerative colitis	8.83e-06	0.0003	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAML2—ulcerative colitis	8.79e-06	0.000299	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TP53—ulcerative colitis	8.66e-06	0.000294	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCL8—ulcerative colitis	8.5e-06	0.000289	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL20—ulcerative colitis	8.47e-06	0.000288	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—JAK2—ulcerative colitis	8.45e-06	0.000287	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GHRL—ulcerative colitis	8.42e-06	0.000286	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTGER4—ulcerative colitis	8.27e-06	0.000281	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ALB—ulcerative colitis	8.18e-06	0.000278	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTGER4—ulcerative colitis	8.16e-06	0.000277	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALM3—ulcerative colitis	8.15e-06	0.000277	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—ulcerative colitis	8.12e-06	0.000276	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RIPK2—ulcerative colitis	8.03e-06	0.000273	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADRB2—ulcerative colitis	8.02e-06	0.000272	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADCY5—ulcerative colitis	8.01e-06	0.000272	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNA12—ulcerative colitis	7.96e-06	0.00027	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—ulcerative colitis	7.93e-06	0.000269	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL8—ulcerative colitis	7.72e-06	0.000262	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GHRL—ulcerative colitis	7.58e-06	0.000257	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCR2—ulcerative colitis	7.55e-06	0.000256	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL8—ulcerative colitis	7.54e-06	0.000256	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADCY5—ulcerative colitis	7.49e-06	0.000255	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GHRL—ulcerative colitis	7.48e-06	0.000254	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—ulcerative colitis	7.37e-06	0.000251	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALM3—ulcerative colitis	7.34e-06	0.000249	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALM3—ulcerative colitis	7.24e-06	0.000246	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RIPK2—ulcerative colitis	7.23e-06	0.000246	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—ulcerative colitis	7.15e-06	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RIPK2—ulcerative colitis	7.13e-06	0.000242	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR6—ulcerative colitis	7.1e-06	0.000241	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADRB2—ulcerative colitis	6.97e-06	0.000237	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—JAK2—ulcerative colitis	6.87e-06	0.000233	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADCY5—ulcerative colitis	6.8e-06	0.000231	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAML2—ulcerative colitis	6.73e-06	0.000229	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL8—ulcerative colitis	6.27e-06	0.000213	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADRB2—ulcerative colitis	6.27e-06	0.000213	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTGER4—ulcerative colitis	6.25e-06	0.000212	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—JAK2—ulcerative colitis	6.24e-06	0.000212	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADRB2—ulcerative colitis	6.19e-06	0.00021	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—JAK2—ulcerative colitis	6.19e-06	0.00021	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—JAK2—ulcerative colitis	6.1e-06	0.000207	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—ulcerative colitis	5.99e-06	0.000204	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADCY5—ulcerative colitis	5.91e-06	0.000201	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GHRL—ulcerative colitis	5.72e-06	0.000194	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL8—ulcerative colitis	5.7e-06	0.000193	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	5.65e-06	0.000192	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—JAK2—ulcerative colitis	5.62e-06	0.000191	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL8—ulcerative colitis	5.57e-06	0.000189	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—JAK2—ulcerative colitis	5.54e-06	0.000188	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALM3—ulcerative colitis	5.54e-06	0.000188	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RIPK2—ulcerative colitis	5.46e-06	0.000185	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—ulcerative colitis	5.44e-06	0.000185	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—ulcerative colitis	5.4e-06	0.000183	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—ulcerative colitis	5.32e-06	0.000181	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADCY5—ulcerative colitis	5.32e-06	0.000181	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADCY5—ulcerative colitis	5.25e-06	0.000178	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL8—ulcerative colitis	5.13e-06	0.000174	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL8—ulcerative colitis	5.06e-06	0.000172	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—JAK2—ulcerative colitis	4.99e-06	0.00017	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—ulcerative colitis	4.9e-06	0.000166	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RELA—ulcerative colitis	4.84e-06	0.000164	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—ulcerative colitis	4.83e-06	0.000164	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	4.73e-06	0.000161	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	4.67e-06	0.000159	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL8—ulcerative colitis	4.56e-06	0.000155	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—ulcerative colitis	4.36e-06	0.000148	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—ulcerative colitis	4.33e-06	0.000147	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.29e-06	0.000146	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.26e-06	0.000145	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	4.24e-06	0.000144	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—ulcerative colitis	4.12e-06	0.00014	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFKB1—ulcerative colitis	4.08e-06	0.000139	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	4.07e-06	0.000138	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	4.02e-06	0.000137	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	3.87e-06	0.000132	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.86e-06	0.000131	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—ulcerative colitis	3.7e-06	0.000126	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—JAK2—ulcerative colitis	3.69e-06	0.000125	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—STAT3—ulcerative colitis	3.67e-06	0.000125	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RELA—ulcerative colitis	3.57e-06	0.000121	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—ulcerative colitis	3.4e-06	0.000115	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL8—ulcerative colitis	3.36e-06	0.000114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—JAK2—ulcerative colitis	3.32e-06	0.000113	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—JAK2—ulcerative colitis	3.27e-06	0.000111	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—ulcerative colitis	3.22e-06	0.000109	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RELA—ulcerative colitis	3.21e-06	0.000109	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—ulcerative colitis	3.2e-06	0.000109	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RELA—ulcerative colitis	3.17e-06	0.000108	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—ulcerative colitis	3.04e-06	0.000103	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	3.03e-06	0.000103	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFKB1—ulcerative colitis	3.01e-06	0.000102	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.01e-06	0.000102	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	2.99e-06	0.000102	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—ulcerative colitis	2.89e-06	9.83e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—ulcerative colitis	2.88e-06	9.78e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—ulcerative colitis	2.86e-06	9.7e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—ulcerative colitis	2.84e-06	9.65e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.8e-06	9.53e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—ulcerative colitis	2.8e-06	9.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—ulcerative colitis	2.74e-06	9.31e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	2.71e-06	9.21e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—STAT3—ulcerative colitis	2.71e-06	9.19e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—ulcerative colitis	2.7e-06	9.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	2.67e-06	9.09e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—ulcerative colitis	2.56e-06	8.7e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—ulcerative colitis	2.51e-06	8.52e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—JAK2—ulcerative colitis	2.51e-06	8.51e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—STAT3—ulcerative colitis	2.44e-06	8.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RELA—ulcerative colitis	2.43e-06	8.24e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—STAT3—ulcerative colitis	2.4e-06	8.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	2.29e-06	7.77e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	2.26e-06	7.67e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	2.23e-06	7.57e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—ulcerative colitis	2.19e-06	7.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—ulcerative colitis	2.17e-06	7.39e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.09e-06	7.1e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—ulcerative colitis	2.07e-06	7.03e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—ulcerative colitis	2.06e-06	7.01e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	2.05e-06	6.95e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—ulcerative colitis	1.89e-06	6.42e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—ulcerative colitis	1.88e-06	6.39e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—ulcerative colitis	1.86e-06	6.31e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—STAT3—ulcerative colitis	1.84e-06	6.25e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—ulcerative colitis	1.83e-06	6.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	1.7e-06	5.79e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—ulcerative colitis	1.7e-06	5.78e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—ulcerative colitis	1.68e-06	5.7e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.64e-06	5.59e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—ulcerative colitis	1.4e-06	4.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—ulcerative colitis	1.28e-06	4.36e-05	CbGpPWpGaD
